Our purpose was to determine whether the action of oxidative free radicals released by endothelial cells and vascular smooth muscle cells grown in culture could be responsible for certain modifications to low density lipoprotein (LDL). In these experiments we showed that after a 48-hour incubation with human umbilical vein endothelial cells or bovine aortic smooth muscle cells, human LDL: 1) became oxidized, as evidenced by reactivity to thiobarbituric acid; 2) lost variable amounts of sterol relative to protein (up to 20%); 3) had an increased relative electrophoretic mobility (by 30% to 70%); and 4) became toxic to proliferating fibroblasts. None of these changes occurred after a 48-hour incubation with confluent fibroblasts or bovine aortic endothelial cells, and all could be virtually prevented by the presence of butylated hydroxytoluene or other free radical scavengers. The results suggest that cells modifying LDL do so in part by an oxidation of LDL subsequent to cellular generation of free radicals.
S everal investigators have reported that low density lipoprotein (LDL) is toxic to cultured vascular cells under certain conditions. 1 " 3 Our more recent results indicated that toxic LDL is formed by oxidation of a lipid component of the lipoprotein during its isolation from plasma if antioxidants are insufficient. 4 We have also demonstrated that this oxidation occurs by a free radical mechanism that involves superoxide anion and/or hydrogen peroxide. 5 Although oxygen-free radicals such as these have been implicated as effectors of tissue damage, 6 ' 7 the toxic action of oxidized LDL is effected by an oxidized lipid producad by free radicals rather than by free radicals generated during propagation of the oxidation reaction. 5 Henriksen, et al. 8 " 10 have reported that cultured human umbilical vein endothelial cells (EC) and vascular smooth muscle cells (SMC), but not human fibroblasts or bovine aortic EC, can modify LDL. The changes in LDL produced by incubation with human umbilical vein EC and SMC include increased anodic electrophoretic mobility, a reduced ratio of total cholesterol to protein, and increased degradation by macrophages. 8 " 10 Bowman et al. 11 have reported that pulmonary artery EC, but not lung fibroblasts, produce superoxide anion in vitro. Since superoxide anion appeared to be involved in spontaneous oxidation of LDL during its isolation, 5 we chose to determine whether cultured EC and SMC could oxidize LDL and render it cytotoxic and to identify the relationship between oxidation and certain other EC modifications of LDL, including the changes in electrophoretic mobility and the decreased steroi content reported by Henriksen et al.
Methods

Cell Preparation
The methods for preparation of human umbilical vein EC, bovine aortic EC, and bovine aortic SMC have been described by DiCorleto and Bowen-Pope. 12 Briefly, primary cultures of bovine aortic EC were isolated by previously used methods in 5% bovine cell-free plasma-derived serum, 13 which was prepared from citrated bovine whole-blood serum. Bovine aortic EC were subcultured in 5% bovine plasma-derived serum in Dulbecco-Vogt modified Eagle's medium (Dulbecco-Vogt medium) supplemented with sodium bicarbonate, penicillin, streptomycin, nonessential amino acids, and sodium pyruvate as described by Glenn et a\. u Bovine aortic EC were subcultured in 75 cm 2 flasks (Falcon, Cockeysville, Maryland) with trypsin at a split ratio of 1:3 and used in this study in passage [15] [16] [17] [18] [19] [20] . Human umbilical vein EC were isolated by published methods 15 and used for experiments when primary cultures were confluent (5 days). The umbilical cords were collected in sterile phosphate-buffered saline (PBS) and later irrigated with PBS followed by 0.25% trypsin in PBS. After collection, the cells were resuspended and cultured in Dulbecco-Vogt medium with 20% fetal bovine serum. Bovine aortic SMC were obtained from explants of intima-media 16 and maintained in Dulbecco-Vogt medium containing 5% bovine serum. The cells were utilized in passage 2 -10 (split ratio of 1:3). These cells were switched to Morgans M-199 medium (GIBCO, Grand Island, New York) containing 10% fetal bovine serum (MA Bioproducts, Walkersville, Maryland) as they neared confluence. Human skin fibroblasts were obtained from neonatal foreskins after circumcision and explanted into 25 cm 2 flasks (Falcon). Explants were placed in M-199 medium (GIBCO) supplemented with 10mM Hepes buffer and 15% fetal bovine serum (MA Bioproducts) in a humidified 5% CO 2 and air environment. Cells were subcultured into 75 cm 2 flasks after 3 to 4 weeks when sufficient peripheral growth had occurred. Fibroblasts in passages 2 through 8 were used for experimentation.
Incubations of LDL with Cells
Confluent 25 cm 2 flasks of cells were rinsed twice with Hanks balanced salt solution. The flasks were incubated for 48 hours in serum-free M-199 supplemented with 10% (by volume) LDL (500 £ig LDL chol/ ml final concentration) or LDL + antioxidant (butylated hydroxytoluene, BHT, 20 /u,M; vitamin E, 22 /j,m; or glutathione, 1.0 mM; Sigma Chemical Company, St. Louis, Missouri). BHT or vitamin E (100 x concentrate in ethanol) was added to make 1% of final volume. The cell media following incubation were centrifuged for 10 minutes at 1000 g to remove any cell debris before being assayed. The number of cells per flask at the end of the incubation was determined by hemacytometer counts following trypsinization.
Lipoprotein Preparation
LDL was prepared from freshly drawn (<24 hour) citrated human plasma from normolipemic donors (plasmas from several donors were used in these studies) according to the method of Hatch and Lees. 17 Plasma solvent density was adjusted to 1.019 with a high density salt solution (containing NaCI, KBr and EDTA). After centrifugation for 18 hours at 60,000 rpm, 5° C in a Beckman L5-75 ultracentrifuge using a 60 Ti rotor, the infranatant was collected. The pooled infranatant was adjusted to density 1.060, recentrifuged as before, and LDL, (d = 1.019-1.060 g/ml) was collected. This is the fraction referred to as LDL in this paper; it was used for all experimentation. Lipoprotein-deficient serum (LPDS, d > 1.25 g/ml) was prepared from pooled human serum. LDL and LPDS preparations were dialyzed at 4° C for 48 to 66 hours against four changes of at least 50 volumes of isotonic saline (0.15 M NaCI) with 0.05% EDTA, adjusted to pH 7.2-8.0.
After filtration sterilization (0.45 jum, Millipore, Bedford, Massachusetts) of the LDL or LPDS, protein concentrations were determined by the method of Lowry et al. 18 Cholesterol concentrations were determined by the Lipid and Lipoprotein Laboratories of the Cleveland Clinic Foundation (modified method of Trinder 19 ; standardized and certified by the Center for Disease Control, Atlanta, Georgia).
Human lipoprotein preparations were analyzed by agarose gel electrophoresis as described below. Samples were applied to the agarose plates at equal cholesterol concentrations.
Assay for Thiobarbituric Acid-Reacting Substances (TBARS)
A modification of the spectrophotometric assay described by Schuh et al. 20 was used to determine the malondialdehyde-like content of the lipoprotein samples and supernatants. Lipoprotein samples were assayed by adding 1 ml of 20% trichloroacetic acid (TCA) to 100 y.\ of lipoprotein of known protein, cholesterol, and triglyceride content. One ml of 1 % thiobarbituric acid was then added and the mixture (pH < 1) was incubated at 95° C for 45 minutes, cooled and subsequently centrifuged at 1000 g for 20 minutes. The absorbance of the supernatant was determined at 532 nm using a Gilford 250 spectrophotometer. Freshly diluted malondialdehyde bis (dimethyl acetal) (1,1,3,3,-tetramethoxypropane, Aldrich, Milwaukee, Wisconsin) was used as a standard.
The supernatants from the cell incubation were assayed for malondialdehyde-like activity in an analagous manner except that 1 ml of 25% TCA was added to 400 fi\ of supernatant and standards before adding 1 ml of 1% thiobarbituric acid.
In the studies reported here, the LDL used contained no detectable TBARS at the beginning of each experiment.
Electrophoresis
Agarose gel electrophoresis was performed using a Corning cell (Palo Alto, California). Single 1 fi\ application of LDL or double 1 /xl applications of cell supernatants (which contained serum-free medium with LDL) were applied to each lane of the gel. Non-incubated lipoprotein used for comparison with cell supernatants was first diluted to the same approximate concentration as the supernatants and applied to the gel in the same manner. Each side of the cell was filled with 95 ml cold barbital buffer (PHAB, Corning). The gel was run in this buffer for 30 minutes, then dried in a 60°C oven for 30 minutes. The gels were lipid-stained with fat red 7B for 4 to 5 minutes, rinsed in destaining solution (methanol/distilled water, 2:1) followed by distilled water, and dried. The relative electrophoretic mobility of each sample was evaluated by measuring the distance in millimeters from the origin to the middle of the fat red-stained band. The mobility was then expressed as a ratio of the sample mobility to that of the nonoxidized, control LDL.
Cytotoxlcity Assay
Fibrobasts were trypsinized and plated into 16mm 24-well plates (GIBCO) in medium M-199 with 15% fetal calf serum 24 hours before the start of the assay. Cell seeding densities of 18,000 to 22,000 cells per well were routinely used for cytotoxicity detection. Before adding the supernatants or reisolated LDL fractions, all cultures were rinsed twice with Hanks balanced salt solution. The supernatants from the previous cell incubations (e.g., with SMC or umbilical vein EC) were supplemented with LPDS (10% final volume) and were added to the wells of fibroblasts for 3 days of study. After 66 hours, the cells remaining attached to the dish were trypsinized and counted in a ZBI Coulter Counter. The use of the number of cells remaining attached to the dish at the end of the experiment as an index of cytotoxicity has been previously shown 4 to correlate with other measures of cell injury, such as trypan blue uptake and lactate dehydrogenase release into the medium.
Reisolation of LDL
The supernatants from the various incubations that contained serum-free medium and LDL were adjusted to a solvent density of 1.100 with high density salt solution and spun in a 50.3 rotor at 50,000 rpm for 22 hours in a Beckman L5-75 ultracentrifuge, collected and dialyzed as indicated above. The purpose of the spin was to reisolate LDL. A solvent density of 1.100 was used to collect LDL that might have increased in density as indicated by Henriksen, et al. 9 ' 10 The reisolated LDL was then assayed for cholesterol, protein, TBARS, electrophoretic mobility, and cytotoxicity.
Llpld Extraction of Cell Supernatants
Lipids were extracted from cell supernatants with chloroform/methanol (2:1, vol/vol) as previously described. 4 The nitrogen-dried extracts were redissolved in acetone/ethyl alcohol (1:1, vol/vol) and were added to fibroblast culture medium to make a final medium concentration of 2.5% solvent in both control and experimental dishes. Determination of TBARS was performed on aliquots of the lipid extracts and the corresponding supernatants.
Results
The purpose of these studies was to determine whether oxidation by cell-generated free radicals plays a role in the modification of LDL. Our results show that incubation of LDL in serum-free medium with human umbilical vein EC or bovine aortic SMC, but not human fibroblasts or bovine aortic EC, resulted in a modified LDL with increased electrophoretic mobility. These findings are in general agreement with the results of Henriksen et al. 8 " 10 Like these authors, 10 we observed that the electrophoretic mobility change was accompanied by a variable decrease in the LDL sterol. A decreased total cholesterol/protein ratio of up to 20% was observed after 48 hours of incubation of LDL with human umbilical vein EC or bovine SMC.
As indicated in Table 1 , however, our results show that the increase in electrophoretic mobility of LDL incubated with human EC or bovine SMC correlated with oxidation as measured by the presence of thiobarbituric acid reacting substances (TBARS). Bovine SMC caused more oxidation of LDL and a greater increase in electrophoretic mobility (even on a per-cell basis) than did human umbilical vein EC. In all cases the distribution of LDL upon electrophoresis was unimodal, showing only a single band after lipid staining. BHT, a general free radical scavenger, virtually prevented the oxidation and the change in electrophoretic mobility observed with human EC and bovine SMC. Table 1 also shows that the presence of TBARS in the supernatants from incubations with human umbilical vein EC or bovine SMC correlated with the cytotoxicity observed when these supernatants were added to fibroblasts. The presence of BHT during the human EC and bovine SMC incubations inhibited the cytotoxicity of the cell supernatants to fibroblasts. In a separate experiment, we determined that BHT also inhibited LDL sterol loss. In this experiment, LDL cholesterol was reduced from 500 ^tg/ml medium to 390 /ng/ml after a 48-hour incubation with 2 x 10 6 human umbilical vein EC. Protein concentration was unchanged. However, when BHT was included, the LDL cholesterol was 470 /xg/ml after 48 hours and the cytotoxicity, increased electrophoretic mobility, and increased TBARS were prevented.
In other experiments similar to those shown in Table 1 , it was found that glutathione (1.0 mM, final media concentration) and vitamin E (22 piM), like BHT, decreased the oxidation of LDL as measured by TBARS (data not shown). In addition, these antioxidants also decreased the electrophoretic mobility changes and resulted in LDL which was less toxic to proliferating fibroblasts. We have also determined that these antioxidants have no effect by themselves on fibroblast growth or viability. Control groups TBARS values are averages of duplicates. Relative electrophoretic mobility is the ratio of the mobility of LDL in the experimental supernatant to that of LDL prior to its addition to culture.
Cell survival data are averages of triplicates ± SEM. Starting fibroblast number was 22,880 ± 1180. Control dishes of fibroblasts to which supematants from the cell-free incubations of LDL were added had 38,760 ± 820 fibroblasts remaining at 66 hours. Control dishes of fibroblasts to which supematants from the cell-free incubations of LDL + BHT were added had 39,220 ± 580 fibroblasts remaining at 66 hours. matched for the ethanol carrier used with BHT and vitamin E indicate no effect of ethanol on the experimental results.
We wished to ascertain whether the cytotoxic compound(s) and the oxidized component(s) which reacted with thiobarbituric acid were associated with LDL. Therefore, LDL was reisolated by ultracentrifugation from supematants after 48-hour incubations with human umbilical vein EC, bovine aortic EC, and human skin fibroblasts. The results displayed in Table 2 indicate that, as expected, only the supernatant from the human umbilical vein EC was significantly oxidized and was subsequently cytotoxic to growing fibroblasts. The isolated fraction containing the LDL accounted for all of the TBARS in this supernatant and was virtually as cytotoxic as the supernatant even at one-half the LDL concentration. (We would not expect a concentration of toxic LDL of 500 /xg Table 2 Relative electrophoretic mobility is the ratio of the mobility of LDL in the experimental supernatant to that of LDL in the supernatant incubated cell-free.
. Concentration of Cell-Generated TBARS, Relative Electrophoretic Mobility, and Fibroblast Toxiclty of LDL In 48-Hour Cell Supematants and Reisolated LDL Fractions
Cell groups for LDL incubation
Cell survival data are averages of triplicates ± SEM. Starting fibroblast number was 19,840 ± 420. Control dishes of fibroblasts to which supematants from the cell-free incubations were added had 34,640 ± 420 fibroblasts remaining at 66 hours. Control dishes of fibroblasts to which LDL reisolated from cellfree supematants was added had 31,100 ± 680 fibroblasts remaining at 66 hours. LDL cholesterol/ml medium to be more toxic than 250 /xg LDL cholesterol/ml medium since our previous studies of the concentration versus cell survival indicated that, in our 66-hour assay, maximal cytotoxicity is achieved at about 250 /xg LDL cholesterol/ml medium when LDL is oxidized. 4 
)
To determine whether the TBARS and the cytotoxic agent were associated with the lipid or protein portion of the LDL molecule, we extracted the lipid from the serum-free supernatant and tested the lipid extract for TBARS and cytotoxicity. The results displayed in Table 3 show that virtually all of the TBARS and the cytotoxic potential from the supernatant of a 48-hour incubation of LDL with bovine aortic SMC were in the lipid extract. The lipid extracts from the supernatants of 48-hour incubations of LDL and BHT or medium alone with bovine aortic SMC were not cytotoxic and did not have any detectable TBARS. Neither TBARS nor cytotoxic agents were detected in media containing LDL which was incubated for 48 hours in the absence of cells. Figure 1 shows correlations among LDL cytotoxicity, LDL oxidation, LDL cholesterol, and changes in electrophoretic mobility of LDL in a human umbilical vein EC supernatant (Figure 1 A) and in a bovine aortic smooth muscle cell supernatant (Figure 1 B) as a function of incubation time. We performed numerous experiments such as those depicted in Figure 1 using LDL concentrations of 500 /xg or 1000 /xg LDL chol/ml medium. The degree of oxidation and the extent of change in the electrophoretic mobility varied from one experiment to the other as can be seen by comparing the 48-hour levels in Figure 1 with the human endothelial cell and bovine aortic smooth muscle cell entries in Table 1 . Despite these variations, detectable changes in electrophoretic mobility of LDL exposed to umbilical vein EC or vascular SMC did not occur without preceding or concurrent oxidation and decreases in LDL total cholesterol. As sterol loss and oxidation continued, the oxidized LDL became more toxic when applied to the proliferating fibroblasts, and the electrophoretic mobility increased further. All of the changes shown in Figure 1 could be inhibited or prevented by the addition of antioxidants to the incubating medium.
The antioxidants did not have to be present at the start of the incubation in order to prevent the changes in LDL oxidation, cytotoxicity, relative electrophoretic mobility, and sterol content. As shown in Table 4 , the addition of BHT at 2 hours after the start of the LDL incubation prevented all the changes seen at 48 hours. When BHT was added at 4 hours, some oxidation was seen at 48 hours and there was a slight change in electrophoretic mobility even though no sterol loss was detected. The addition of BHT as late as 12 hours after the start of the incubation inhibited but did not prevent oxidation, cytoxicity, sterol loss and the change in electrophoretic mobility.
In experiments in which spontaneous (cell-free) oxidation of LDL was allowed to take place by 4°C dialysis against isotonic saline without EDTA, 34 TBARS as high as 1.0 nmol MDA/mg LDL cholesterol were obtained with no change from normal electrophoretic mobility. When this oxidized LDL was then incubated in cell-free medium at 37°C, TBARS increased (from 1.0 nmol MDA/mg LDL cholesterol at zero time to 2.8 at 24 hours and 4.5 at 48 hours), as did electrophoretic mobility (by 17% at 24 hours and 33% by 48 hours).
Table 3. Incubation of LDL with Bovine Aortic Smooth Muscle Cells: Resulting Concentrations of TBARS and FIbroblast Survival after Exposure to LDL-Containing Supernatants or Their Lipid Extracts
Cell groups for LDL incubation LDL concentration was 560 /xg LDL chol/ml medium. BHT concentration in the incubation was Supematants were added directly to fibroblasts.
TBARS values are averages of duplicates. Relative electrophoretic mobility is the ratio of the mobility of LDL in the experimental supernatant to that of LDL prior to its addition to culture.
Cholesterol values are the average of duplicates. Cell survival data are averages of triplicates ± SEM. Starting fibroblast number was 9247 ± 972. Control dishes of fibroblasts to which medium + LPDS were added had 15,060 ± 220 cells remaining at 66 hours.
Discussion
The data presented in this report add to the findings of Henriksen, et al. 8 " 10 regarding modifications of LDL by certain vascular cells in culture. The recent report by Bowman et al." indicated that under certain conditions, pulmonary aortic EC produce superoxide anion, one of the oxidative free radicals which our previous studies 5 implicated in the oxidation of LDL. This finding led us to theorize that the modification of LDL by EC and SMC might involve oxidation. Our previous studies 45 showed that LDL-induced cytotoxicity was correlated with oxidation detected by an assay for TBARS and that various antioxidants, including BHT, a general free radical scavenger, could inhibit or prevent the oxidation of LDL and its subsequent cytotoxicity.
In the present studies we again employed BHT and other antioxidants to explore the possibility that LDL modification by human EC and bovine SMC was related to LDL oxidation by cell-generated free radicals. Our results without BHT were consistent with those of Henriksen et al. 8 " 10 in that LDL was modified by incubation with human umbilical vein EC and by SMC but not by human fibroblasts or bovine aortic EC. The presence of BHT, however.during the incubation of LDL with umbilical vein EC or bovine aortic SMC, virtually prevented the modifications of LDL. The modifications that BHT prevented include the change in electrophoretic mobility, the oxidation as detected by the thiobarbituric acid assay, the loss in LDL total cholesterol (or decrease in cholesterol/protein ratio) and the cytotoxicity observed when the supernatants from the 48-hour cell incubation were added to subconfluent fibroblast cultures for 66 hours. The facts that the TBARS content and the toxic agent(s) were recovered in the LDL fraction (Table 2) or the lipid extract (Table 3 ) of the cell supernatants are consistent with our previous studies 4 showing the toxicity of oxidized LDL.
The thiobarbituric acid assay is a nonspecific assay for malondialdehyde or malondialdehyde-like molecules. Malondialdehyde is a by-product of oxidation and its measurement has been used as an indicator of oxidation. The protocols used by investigators to measure TBARS vary widely, and the sensitivity and specificity of the assay are highly dependent on factors such as the pH of the reaction mixture. 21 Oxidation, as measured by our assay, was the change most consistently observed first in the incubation of umbilical vein EC or bovine aortic SMC with LDL. Although oxidation and sterol loss appeared to occur concurrently in the time course experiments before any change in relative electrophoretic mobility or cytotoxicity was noted (see Figure 1 ), when BHT was added 4 hours into the incubation, only oxidation and a slight change in relative electrophoretic mobility were detected (Table 4 ).
It is interesting to compare the effects of LDL of cell-free, spontaneous, free radical-mediated oxidation with those of cell-mediated oxidation. The find-ing of detectable LDL oxidation in the cell-free control without a significant change in electrophoretic mobility is consistent with our previous observation 4 that LDL oxidized during cold dialysis without EDTA did not exhibit increased electrophoretic mobility. We have also shown 4 that spontaneous (cell-free) oxidation of LDL can be sufficient to render the LDL cytotoxic without a detectable change in cholesterol/protein ratio or in electrophoretic mobility. Thus, oxidation, but neither a change in electrophoretic mobility nor sterol loss, appears necessary for the expression of LDL-induced cytotoxicity. Furthermore, we found that after cell-free, spontaneous oxidation of LDL at 4°C, incubation in cell-free medium at 37°C allowed oxidation to continue further and led to an increase in electrophoretic mobility. This indicates that cells are not required for the increase in electrophoretic mobility of previously oxidized LDL to occur.
Loss of LDL sterol observed by Henriksen et al. 10 and confirmed by us may occur due to sterol solubilization following oxidation. Krut reported 22 that sterols became more soluble in aqueous solution when oxidized. It is not possible from our results to infer the relationship between oxidation, sterol loss, and alteration of electrophoretic mobility. The separation of these changes is important since many, 23 " 25 including Henriksen et al., 8 " 10 have observed that various modifications of LDL leading to increased electrophoretic mobility increase the degradation of LDL by macrophages.
The reason why some cell types, but not others, can oxidize and modify LDL is unknown. Different cell types may possess different free radical generating systems or they may have different inherent antioxidant capacities.
At least 2 hours of incubation were required to initiate the process that resulted in LDL modification at the end of the 48-hour incubation. The mechanism by which cells modify LDL is as yet unclear. Henriksen et al. 10 suggested retroendocytosis, described by Aulinskas et al., 26 as a possible explanation. It is possible that the LDL is oxidized intracellularly by free radicals produced there. While free radicals are short-lived, it is also plausible that LDL oxidation occurs at or near the cell surface. If intracellular processing occurred, one might expect to observe evidence of two molecular populations at early times representing modified and unmodified LDL. However, the density distribution of LDL 9 ' 10 and the electrophoretic mobility distribution of LDL as it changes with time during cell-mediated modification were not bimodal.
Whether EC or SMC produce free radicals in vivo is unknown, and the intracellular or interstitial concentrations of naturally occurring free radical scavengers which would inhibit the peroxidation of lipoprotein lipids by nearby cells are likewise unknown. Nevertheless, it is worth noting that apolipoprotein Bcontaining lipoproteins recovered from arterial tissue have reportedly 27 had an increased electrophoretic mobility compared to plasma LDL. A toxic lipoprotein existing in arterial interstitium could conceivably be responsible for some of the dead cell debris found in atherosclerotic plaques.
